
Areef Ishani MD
Associate Professor, Medicine, University of Minnesota Medical School
Join to View Full Profile
1 Veterans Dr # 111jMinneapolis, MN 55417
Phone+1 612-725-2098
Fax+1 612-727-5640
Dr. Ishani is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Areef Ishani, MD, is a nephrology specialist based in Minneapolis, MN. He completed his residency in internal medicine and fellowship in nephrology at the University of Minnesota. He graduated from the University of Toronto Faculty of Medicine in 1996. Dr. Ishani has expertise in critical care medicine and has contributed to several publications, including those focusing on hemodialysis care and the treatment of hypertension. He has also been involved in clinical trials aimed at improving outcomes for patients with chronic kidney disease and diabetes.
Education & Training
University of MinnesotaFellowship, Nephrology, 2000 - 2002
University of MinnesotaResidency, Internal Medicine, 1996 - 2000
University of Toronto Faculty of MedicineClass of 1996
Certifications & Licensure
MN State Medical License 1999 - 2026
American Board of Internal Medicine Nephrology
Clinical Trials
- Effect of Care Management on Diabetes Outcomes Start of enrollment: 2006 Sep 01
- Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD) Start of enrollment: 2012 Mar 01
Publications & Presentations
PubMed
- Home Blood Pressure Monitoring in Routine Care-Factors Associated with Enrollment and Blood Pressures Recorded in the Veterans Health Administration.Bethany C Birkelo, Adam Kaplan, Andrea Cutting, Brent Taylor, Karen L Margolis
American Journal of Hypertension. 2026-05-01 - Pharmacist Outreach and SGLT2 Inhibitor Uptake in Patients With Diabetes and Chronic Kidney Disease.Deborah L Pestka, Daniel Murphy, Adam N Kaplan, Brent C Taylor, Pearl Huynh
JAMA Network Open. 2026-05-01 - Per-Protocol Analysis of Chlorthalidone Versus Hydrochlorothiazide for Cardiovascular Event Prevention-Diuretic Comparison Project.Sonia T Anand, Cynthia Hau, Michael J Davenport, Areef Ishani, William C Cushman
Journal of the American Heart Association. 2026-02-03
Journal Articles
- Race, Ethnicity, and End-of-Life Care in Dialysis Patients in the United StatesPaul Drawz, Scott Reule, Robert N Foley, Areef Ishani, Journal of the American Society of Nephrology
Press Mentions
One Diuretic May Be Better for Hypertensive Patients with Kidney Stone HistoryApril 11th, 2025
Chlorthalidone Not Superior to Hydrochlorothiazide for HypertensionDecember 26th, 2024
New Analysis on Hypertension Treatment Presented as Late-Breaking Research at National Kidney Foundation Spring Clinical MeetingsMay 16th, 2024
Grant Support
- Home Blood Pressure Outcomes Evaluation Study (HOMESTEAD)UNIVERSITY OF MINNESOTA2022–2026
- Outcomes/Costs Related To Frequency Of Physician-Patient Visits On HemodialysisNational Institute Of Diabetes And Digestive And Kidney Diseases2011–2012
- Outcomes And Costs Associated With Frequency Of Physician-Patient Visits On HemodNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- The Long-Term Consequences Of Postoperative Acute Kidney InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









